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ABSTRACT 
 
COST-EFFECTIVENESS OF TELEHEALTH FOR CHRONIC CARDIOVASCULAR 
CONDITIONS AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THE UNITED 
STATES 
 
By 
 
TRISHNA KINI 
 
May 29, 2019 
 
 
  
 
 
INTRODUCTION:  The United States has seen a dramatic increase in the incidence of chronic 
disease, including chronic obstructive pulmonary disease (COPD) and chronic cardiovascular 
diseases. Telehealth interventions can potentially improve healthcare access and health outcomes 
in the United States while saving time and economic resources. Conclusive research is needed to 
show whether telehealth interventions are cost-effective for people living with chronic disease.  
 
AIM: This paper synthesizes the existing literature on the cost-effectiveness of telehealth 
interventions for patients with chronic cardiovascular conditions (congestive heart failure (CHF), 
myocardial infarctions, and coronary heart disease) and chronic obstructive pulmonary disease 
(COPD). 
 
METHODS: A literature search was undertaken to identify studies that assessed the cost-
effectiveness of telehealth interventions for chronic cardiovascular diseases and chronic 
obstructive pulmonary disease (COPD) using PubMed and Scopus.  
 
RESULTS:  A thorough literature search using PubMed and Scopus identified 753 articles that 
fit the search criteria. Of these, 27 articles met inclusion criteria, including  9 literature reviews 
and 1 meta-analysis. Over 80% of the relevant research was conducted in Europe, Taiwan, and 
Australia. The combination of a lack of cost-effectiveness research conducted in the United 
States, methodological challenges in the existing studies, and continued technological 
advancements, make it clear that further research is needed to make reliable inferences and 
conclusions. 
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I. Introduction 
 
The United States has seen a dramatic increase in the incidence of chronic disease, including 
chronic obstructive pulmonary disease (COPD) and chronic cardiovascular diseases such as 
congestive heart failure (CHF) (Centers for Disease Control and Prevention, 2015). Many factors 
have increased the incidence of chronic disease including social determinants of health (underlying 
socioeconomic, cultural, political and environmental determinants) in addition to individual risk 
factors (tobacco use, lack of physical exercise, unhealthy diet, age, and genetics) (World Health 
Organization, 2005). Social determinants of health impact access and research has found that 
poorer access to healthcare has contributed to the increase in chronic disease (Brooks et al., 2010). 
Telehealth interventions can potentially improve healthcare access and health outcomes in the 
United States while saving time and economic resources. Telehealth provides the option to deliver 
health services to patients remotely through telecommunication technologies such as web-based 
video chat capabilities, telephone consultations, and at-home monitoring (Botsis and Hartvigsen, 
2008). Since people do not have to travel as far or as often to see a doctor, telehealth has the 
potential toincrease access to care.  
Access to healthcare remains a significant challenge in the United States, especially in rural 
communities that have older, poorer, and sicker residents compared to their urban counterparts 
(Health Resources and Services Administration, 2015). Unfortunately, rural areas also have fewer 
primary care physicians and significant physician mobility (McGrail et al., 2017). Telehealth has 
been identified as a potential strategy to increase healthcare access in communities that are 
geographically isolated (Rosenblatt & Hart, 2000). Telehealth interventions can potentially help 
people manage their chronic diseases and improve health outcomes and rural health disparities. 
Once the effectiveness of a new medical treatment or technology has been established, it is often 
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necessary to demonstrate the cost-effectiveness in order to increase adoption, especially when 
start-up costs are high. One potential barrier to the adoption of telehealth interventions is the 
uncertainty about start-up costs and  the cost-effectiveness of these interventions. Research 
assessing the cost effectiveness is critical for informing these decisions. 
While there has been research to determine cost-effectiveness of telehealth, no study to-date 
has shown conclusive evidence that these interventions are cost-effective in the United States. This 
analysis compiles and reviews the existing literature on the cost-effectiveness of telehealth 
interventions for chronic cardiovascular diseases and COPD. 
II. Methodology 
A literature search was undertaken to identify studies that assessed the cost-effectiveness 
of telehealth interventions for chronic cardiovascular diseases and chronic obstructive pulmonary 
disease (COPD) using the following two databases: PubMed and Scopus. Utilizing PubMed’s 
medical subheadings (MeSH) resource by searching the subheadings telemedicine1 and cost benefit 
analysis2 led to the identification of 753 articles. All 753 results were then transferred to EndNote 
where abstracts were reviewed to determine if the study met the inclusion criteria for this review. 
These criteria included studies published in English, published between January 1, 2000-August 
31, 2017, included a cost-effectiveness evaluation, and looked at the impact on patients with COPD 
and chronic cardiovascular disease, such as congestive heart failure, myocardial infarctions, and 
                                                 
1 Telemedicine is the MeSH entry term for Mobile Health, Health, Mobile, mHealth, Telehealth, and eHealth. 
2 Cost benefit analysis is the MeSH enry term for: Analyses, Cost-Benefit; Analysis, Cost-Benefit; Cost-Benefit 
Analyses; Cost Benefit Analysis; Analyses, Cost Benefit; Analysis, Cost Benefit; Cost Benefit Analyses; Cost 
Effectiveness; Effectiveness, Cost; Cost-Benefit Data; Cost Benefit Data; Data, Cost-Benefit; Cost-Utility Analysis; 
Analyses, Cost-Utility; Analysis, Cost-Utility; Cost Utility Analysis; Cost-Utility Analyses; Economic Evaluation; 
Economic Evaluations; Evaluation, Economic; Evaluations, Economic; Marginal Analysis; Analyses, Marginal; 
Analysis, Marginal; Marginal Analyses; Cost Benefit; Costs and Benefits; Benefits and Costs; Cost-Effectiveness 
Analysis; Analysis, Cost-Effectiveness; and Cost Effectiveness Analysis. 
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coronary heart disease. Exclusion criteria included studies that focused on diseases other than 
chronic cardiac conditions and COPD, studies not written in English, studies that did not conduct 
a physical telehealth intervention, and studies that did not include a cost effectiveness analysis. 
This review process led to the identification of 27 articles that met the inclusion criteria – 17 of 
these articles were research studies, 9 were literature reviews, and 1 was a meta-analysis. Of the 
17 studies, 1 was conducted in Australia, 1 in Belgium, 2 in Canada, 1 in Denmark, 1 in Germany, 
1 in the Netherlands, 1 in Spain, 2 in Taiwan, 3 in the United Kingdom, and 3 in the United States.3  
III. Literature Review 
i) Individual Chronic Cardiovacular Disease Studies  
Five studies performed outside the United States found that telehealth interventions were 
comparable or more cost-effective than usual care for patients with chronic cardiovascular 
diseases. For example, Ho et al. (2014) and Chen et al. (2013), researchers affiliated with their 
Telehealth Center, conducted two studies at the National Taiwan University Health Center during 
different time periods.  The purpose of their studies was to assess the clinical outcomes and cost-
effectiveness of a telehealth program for patients with chronic cardiovascular diseases, including 
1) coronary heart disease with or without percutaneous coronary intervention, 2) myocardial 
infarction, 3) congestive heart failure, 4) arrhythmia, including bradyarrhythmia, tachyarrhythmia, 
or ventricular arrhythmia with an implantable cardiac defibrillator implant, 5) diabetes mellitus, 6) 
syncope, 7) =2 CAD risk factors with angina, and 8) other surgical or congenital heart conditions 
(Chen et al., 2014).  
                                                 
3 One study, Henderson et al., examines the cost-effectiveness of telemedicine for patients with chronic conditions 
including COPD and CHF 
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Ho et al. (2014) retrospectively analyzed 575 patients who had joined a telehealth program and 
compared them with 1178 patients undergoing usual care matched for sex, age, and Charlson 
comorbidity index.4 Their study was conducted between December 2009 and April 2013. They 
matched patients with chronic cardiovascular disease that entered the telehealth program with 
patients that received usual care at their cardiovascular center using age, gender, and the Charlson 
comorbidity index. The telehealth program transmitted biometric data from the patients’ homes, 
and patients had access to decision-making support without seeing a doctor in person. This 
program also included daily phone interviews. The researchers collected data on hospitalization, 
emergency department (ED) visits, and medical costs from the hospital's database and the costs 
were adjusted to the follow-up months. The cost-effectiveness of telehealth care over usual care 
was assessed by using a bootstrap analysis method.5 The data is summarized in the following table: 
Table 3.1. Monthly Cost Data of the Telehealth Program Conducted in Taiwan by Category 
 Control Group mean (SD) Telehealth Group mean (SD) 
ED visits $37.30 (126.20) $20.90 (66.60) 
Hospitalizations $878.20 (2,697.20) $37.30 (126.20) 
All Medical Costs $1,163.60 (3,036.60) $587.60  (1,497.80) 
 
Even though the intervention cost an additional $224.80 per month, total monthly costs ($812.40) 
in the Telehealth Group were still less than all medical costs in the control group, as seen in the 
above table (Ho et al., 2014). Chen et al. (2013) conducted a quasi-experimental study between 
November 2009 and April 2010 recruiting a total of 141 patients who received telehealth services 
at the same hospital in the same program as Ho et al. (2014). They collected data on hospital visits 
                                                 
4This index contains 19 categories of comorbidity and predicts the ten-year mortality for a patient who may have a 
range of co-morbid conditions. Each condition is assigned a score of either 1, 2, 3, or 4 depending on the risk of 
dying associated with this condition. This helps to control for the impact of comorbidities on study outcomes. 
5
A test or metric that relies on random sampling with replacement. Bootstrapping allows assigning measures of 
accuracy (defined in terms of bias, variance, confidence intervals, prediction error or some other such measure) to 
sample estimates.  
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and hospital expenditures for six months before and after the opening of the hospital’s Telehealth 
Center to assess clinical outcomes and cost-effectiveness of the program for patients with 
cardiovascular disease. The study found that the intervention significantly reduced the monthly all 
cause admission rate and the duration of all cause hospital stays. They also found that the 
intervention significantly reduced the monthly inpatient costs and total cost per month (Chen et 
al., 2013). From these studies, one can infer that in Taiwan’s integrated health care system, this 
telehealth intervention was more cost-effective than usual care. 
 Whittaker and Wade’s study (2010) in the United Kingdom, a nation that has a government 
run healthcare system, also found cost savings for a home telehealth-based cardiac rehabilitation 
program. Their randomized controlled trial (RCT) included 120 participants; 60 participants each 
randomly assigned to the telehealth program or to usual care. The telehealth program included a 
cell phone with daily text messaging, a Wellness Diary, and access to a Wellness web portal. Usual 
care consisted of the standard 6-week hospital-based outpatient rehabilitation program. On 
average, the telehealth program saved providers £212 ($307.29)6 and saved patients £320 
($463.84) in travel costs. Both groups showed significant improvements in both clinical 
parameters and health-related quality of life measures. There were no significant differences in 
health outomes between the two groups during the study period. (Whittaker and Wade, 2010). 
Another RCT conducted in Belgium that also studied the effect of home telehealth-based cardiac 
rehabilitation, found cost-savings for the provider, while also providing patients with better health 
outcomes (Frederix et al., 2015). In this study, Frederix et al. (2015) randomized 140 patients into 
two groups: a 24 week long tele-rehabilitation program plus usual care and usual care only. They 
                                                 
6 All exchange rates to US dollars used are of January 1st of the year the study was conducted. 
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found that the intervention group had significant cost savings and fewer lost days to cardiovascular 
rehospitalizations.  
Another study conducted in the United Kingdom by Henderson et al. (2014) recruited 965 
participants within a cluster RCT of 3230 patients to determine incremental cost per QALY 
(quality-adjusted life year) gained for patients with CHF, COPD, and/or diabetes. QALY is a 
generic measure of disease burden, including both the quality and the quantity of life lived. It is 
used in economic evaluation studies to assess the value of the money spent on medical 
interventions and is calculated by multiplying the utility score of being in a certain health state by 
the time that the patient experienced that state. Study participants completed a questionnaire that 
examined telehealth acceptability, effectiveness, and cost effectiveness. In conjunction, hospital 
data was collected to determine cost-effectiveness. The probability of telehealth being cost 
effective was 11% at a willingness to pay threshold of £30000 ($48,778.37) per QALY gained. 
The probability exceeded 50% only if willingness to pay values exceeded £90,000 ($146,335.11). 
Henderson et al. (2014) concluded that telehealth interventions have a low probability of being 
cost-effective. 
Boyne et al. (2013) also conducted an RCT to determine the cost-effectiveness of 
telemonitoring of patients with CHF in the Netherlands. A total of 382 patients in 3 different 
hospitals were randomized to either usual care or telemonitoring and followed for one year. 
Hospital-related and home costs are estimated based on resource use multiplied by the appropriate 
unit prices. Information was gathered from the participants through three monthly cost diaries and 
questionnaires. There were no significant differences in annual costs per patient between groups.  
Boyne et al. (2013) found that health-related quality of life showed slight improvement for the 
telemonotoring group over usual care, but it was not significant. The researchers also found that 
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at a threshold of €50,000 ($64,795) for cost of care, the probability of telemonitoring being cost-
effective was 48%. The cost effectiveness analysis shows a high level of decision uncertainty that 
can probably be explained by the variability between the participating institutions.  
Three studies published between 2001-2008 assess the cost-effectiveness of telehealth 
interventions for the treatment of chronic cardiac diseases in the United States. Two of these 
studies were conducted within the Department of Veterans Affairs Health System.  In particular, 
Darkins et al. (2008) followed patients participating in the Coordinated Care/Home Telehealth 
(CCHT) program between July 2003 and December 2007. This program systematically 
implements health informatics, home telehealth, and disease management technologies with the 
purpose of helping patients live independently at home. CCHT provided services to patients with 
diabetes mellitus (DM), congestive heart failure (CHF), hypertension (HTN), post-traumatic stress 
disorder (PTSD), chronic obstructive pulmonary disease (COPD), and depression. They found that 
CCHT had 25% fewer in-patient days of care and a 19% reduction in the number of hospital 
admissions, six months after enrollment into the program compared to the six months before 
enrollment. The patients enrolled in CCHT reported a mean satisfaction score rating of 86%, 
though the study did not report a satisfaction score rating for patients receiving usual care. Noel et 
al. (2004) conducted a study in the VA Connecticut Healthcare System (VACT) to determine 
whether home telehealth, when integrated with the health facility's electronic medical record 
system, reduces healthcare costs and improves quality of life outcomes relative to usual home 
healthcare services for elderly high resource users with complex heart failure, chronic lung disease, 
and/or diabetes mellitus by randomizing 104 patients to the telehealth program or usual care. The 
researchers found that compared to the control group, the intervention significantly decreased at 
six months the number of days of inpatient hospitalization  (p < 0.0001), emergency room visits 
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(p < 0.023), and A1c levels (p < 0.001).  The third study, conducted by Jerant et al. (2001), 
compared three hospital discharge care models for reducing CHF-related readmission charges: (a) 
home telecare delivered via a 2-way video-conference device with an integrated electronic 
stethoscope; (b) nurse telephone calls; and (c) usual outpatient care in a hospital in Southern 
California. This was a small randomized control trial with 37 participants. After a year, mean CHF-
related readmission charges were 86% lower in the telecare group ($5850, SD $21,094) and 84% 
lower in the telephone group ($7320, SD $24,440) than in the usual care group ($44,479, SD 
$121,214). However, the difference between the telecare group and the nurse telephone group was 
not statistically significant. 
Table 3.2. Telehealth Studies for Patients with Chronic Cardiovascular Diseases 
First Author Year Country 
Type of 
Intervention 
Number of 
Participants 
QALYs 
Used 
Cost-
Effective 
Boyne, J. J. 2013 Netherlands Telemonitoring 382 Yes No difference 
Chen, Y. 2013 Taiwan Telemonitoring 141 No Yes 
Cui, Y. 2013 Canada Nurse call line 179 Yes Yes 
Darkins, A. 2008 United States Telemonitoring 170257 No Yes 
Frederix 2016 Belgium Telemonitoring 140 Yes Yes 
Henderson, C. 2013 United Kingdom Telemonitoring 965 Yes No difference 
Ho, Y. L. 2014 Taiwan Telemonitoring 575 No Yes 
Jerant, A. F. 2001 United States 
Telemedicine 
and Nurse Call 
line 
37 No Yes 
Noel, H. C. 2004 United States  Telemonitoring 104 No Yes 
Sohn, S. 2012 Germany Telemonitoring 1124 No Yes 
Whittaker, F. 2014 United Kingdom Telerehabilitation 120 No Yes 
 
ii) Individual Chronic Obstructive Pulmonary Disease (COPD) studies 
 While the results for the individual studies on cost-effectiveness for chronic cardiac diseases 
are mostly positive, the results of studies that investigate the cost-effectiveness of telehealth 
interventions for patients with COPD are far more varied. From 2013 to 2015, three studies 
                                                 
7 This number includes all Veterans Health Administration (VHA) patients receiving telehealth between July 2003 
and December 2007. 
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published in the United Kingdom assessed the cost-effectiveness of telemonitoring programs for 
COPD patients after discharge from the hospital compared to usual care. The purpose of the 
telemonitoring programs was to reduce emergency department visits and hospital admissions. All 
three studies conclude that the cost of technology outweighed any cost benefit from the program. 
These studies do report slightly better health outcomes in patients in the telemonitoring programs, 
but not enough to justify the extra cost (Henderson et al., 2013, McDowell et al., 2015, and 
Stoddart et al., 2015). 
McDowell et al. (2015) identified 110 patients with COPD to study the effect of adding 
telemonitoring to usual care in Northern Ireland. Their primary outcome was disease specific 
quality of life over six months. They found that telemonitoring improved quality of life but was 
not cost-effective. Stoddart et al. (2015) conducted an RCT that studied the cost and cost-
effectiveness of telemonitoring versus usual care for patients with COPD. They randomized 256 
patients to either telemonitoring or usual care for a 12-month period. The study found the 
intervention only had a 15% probability of being cost-effective at the usual threshold of £30,000 
($37,984) per QALY. As stated earlier, Henderson et al. (2013) found that a telehealth intervention 
for patients with COPD, CHF, and diabetes had a low probability of being cost-effective. 
Interestingly, a RCT over a period of six months of a telemonitoring program conducted in 
Australia found significant cost savings of AUD $2,931 (US$2992) (De San Miguel el al., 2013). 
The study, however, did not find a significant difference in health outcomes (ED visits, hospital 
admissions, and reduced length of stay) even though the telemonitoring group did have marginally 
better outcomes. A telemonitoring study that randomized 57 patients with exacerbated COPD after 
discharge conducted in Denmark also found significant cost savings for COPD patients joining the 
intervention after hospital discharge versus usual care (Jakobsen et al., 2013).   
17 
 
Two telemonitoring studies, one conducted in Canada and the other in Spain, reported 
comparable results to the studies conducted in the United Kingdom. Jodar-Sanchez et al. (2014) 
randomized 45 patients undergoing long-term oxygen therapy for severe COPD into a telehealth 
group and a usual care group. The telehealth group used monitoring devices at home to send in 
vital signs. When a patient triggered an alarm, medical staff triaged the patient and decided on next 
steps. Paré et al. (2006) conducted a quasi-experimental study comparing the costs and effects of 
19 patients in a telecare program to a comparable group of 10 patients receiving usual care. Both 
studies concluded the cost of technology was too expensive to provide significant cost savings 
(Jodar-Sanchez et al., 2014, and Paré et al., 2006).  
Table 3.3. Telehealth Studies for Patients with COPD 
First Author Year Country 
Type of 
Intervention 
Number of 
Participants 
QALYs 
Used 
Cost-
Effective 
De San Miguel, K. 2013 Australia Telemonitoring 102 No Yes 
Henderson, C. 2013 
United 
Kingdom 
Telemonitoring 965 Yes No 
Jakobsen, A. 2013 Denmark Telemonitoring 57 No Yes 
Jodar-Sanchez, F. 2014 Spain Telemonitoring 45 Yes No 
McDowell, J. E. 2015 
United 
Kingdom 
Telemonitoring 100 No No 
Paré, G. 2006 Canada Nurse Call Line 29 No No 
Stoddart, A. 2015 
United 
Kingdom 
Telemonitoring 256 Yes  No 
 
iii) Summary of previous literature reviews  
Previously published reviews also show variation in the cost-effectiveness of telehealth 
interventions for people with chronic cardiac diseases or COPD. There is considerable overlap in 
the studies included in the reviews that fit the selection criteria. Udsen et al. (2014) conducted a 
literature review of the costs and cost-effectiveness of telehealth for patients with COPD. This 
review is the most in depth study and its findings are illustrative of those found in other literature 
reviews. They assess six studies (three from North America and three from Europe) using the 
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Consensus Health Economic Criteria list (CHEC list) to determine the quality of the economic 
evidence presented in each paper. This methodology was created through the Delphi method8 with 
23 international experts. Using this method of economic evaluation in systematic reviews should 
make them more transparent, informative, and comparable (Evers et al., 2005). All studies report 
the use of home monitoring devices that measure and transmit different physical indicators to 
nurses who provide personalized feedback to patients during weekdays. In total, the six studies 
include 559 COPD patients of whom 281 were randomized to the telehealth intervention. While 
all six studies report a lower average cost per patient with telehealth plus usual care compared with 
usual care alone, the authors found the quality of the economic evidence to be either mostly poor 
(5 studies) or moderate (1 study), with CHEC list scores ranging from 21-68%. To provide some 
perspective, within the CHEC list criteria, a score of greater than 75% is considered high quality, 
between 50% and 75% is considered moderate quality, and less than 50% is considered poor 
quality. These authors also recommend that healthcare decision-makers use caution before 
implementing large scale telemedicine programs due to the lack of strong evidence in favor of 
clinical cost-effectiveness.  
Unfortunately, this is the only published review study that focuses exclusively on COPD 
patients. The remaining systematic reviews on telemedicine interventions for COPD patients 
combine studies on a variety of chronic conditions that focus on various outcomes including 
intervention effectiveness and cost-effectiveness (Barlow et al., 2007, Botsis and Hartvigsen, 
2008, Ekeland et al., 2010, Elbert et al., 2014, and Mistry et al., 2014). A possible reason for this 
is the paucity of studies conducted on telemedicine interventions for patients with COPD. Barlow 
et al. (2007) only found 3 studies on this topic, Botsis and Hartvigsen (2008) found 5 studies, 
                                                 
8A forecasting process framework based on the results of multiple rounds of questionnaires sent to a panel of 
experts.  
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Ekeland et al. (2010) found 1 study, and Elbert et al. (2014) found 4 studies. These literature 
reviews come to similar conclusions about the lack of strong evidence showing the cost-
effectiveness of telehealth interventions as Udsen et al. (2014).  
Unlike COPD, there are more reviews of telehealth interventions that focus on heart failure 
patients. Grustam et al. (2014), another group of European researchers, concluded that studies were 
inconclusive with regard to the cost-effectiveness of telehealth interventions for chronic heart 
failure (CHF) patients. They selected 32 studies for data extraction and a critical appraisal of the 
economic evaluation. Not all studies selected were used in their analysis because they do not 
include their own cost effectiveness analysis. Most studies did not present a comparison of both 
costs and effects between telehealth intervention and usual care. In addition, many did not include 
telehealth investment costs. The few studies that assessed cost-effectiveness comprehensively 
showed that telehealth interventions were cost saving with slight improvement in effectiveness, or 
comparably effective with similar cost to usual care. Jerant and Nesbitt (2005), in another review,  
examined the evidence of cost effectiveness of telehealth interventions for patients with heart 
failure. They found 5 prior systematic reviews on the effectiveness/cost-effectiveness of telehealth 
interventions and 33 RCTs. Both Grustam et al. (2014) and Jerant and Nesbitt (2005) excluded 
most of the articles chosen because they did not include enough information to conduct a cost-
effectiveness analysis and concluded that there was a lack of necessary data to prove or disprove 
the cost effectiveness of telehealth interventions for patients with heart failure.  
In 2013, the United Kingdom’s National Health Service (NHS) conducted a technology 
assessment of telemonitoring programs after recent discharge in heart failure patients (Pandor et 
al., 2013). Their literature search identified 3,060 articles. Through their inclusion criteria, 6 RCTs 
were added to the 15 trials identified from the previous systematic reviews to be included in their 
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systematic review and network meta-analyses9. They found telemonitoring during office hours 
was the most cost-effective strategy with an estimated incremental cost-effectiveness ratio (ICER) 
of £11,873 ($19,305) per quality-adjusted life-year (QALY) compared with usual care, whereas 
human telephone support had an ICER of £228,035 ($37,0773) per QALY compared with 
telemonitoring during office hours. They did conclude that their findings were based on less than 
optimal data and that further research is needed (Pandor et al., 2013). Ten years earlier, Louis et 
al. (2003), another group of British researchers, reviewed 5 studies that assessed the cost-
effectiveness for heart failure patients and also concluded that more research is needed. Thus, 
similar to the literature review of COPD, these researchers could not conclude that telehealth 
interventions for CHF patients were cost effective.  
Table 3.4. Previously Published Reviews 
First Author Year Study Description Cost-Effective 
Barlow, J. 2007 Review of studies of home telecare for 
patients with chronic conditions 
Unable to determine 
Botsis, T. 2008 Review of studies of home telecare for 
patients with chronic conditions 
Users felt telecare led to cost reduction 
Ekeland, A. 
G. 
2010 Review of reviews of all telemedicine 
interventions 
Not enough information to conclude the cost-
effectiveness of telemedicine interventions 
Elbert, N. J. 2014 Review of reviews and meta-analyses of 
telehealth interventions for patients with 
somatic diseases  
Attention should be given to the 
development and evaluation of strategies to 
implement effective/cost-effective eHealth 
initiatives in daily practice, rather than to 
further strengthen current evidence 
Grustam, A. 
S. 
2014 Cost-effectiveness of telehealth 
interventions for chronic heart failure 
patients 
Without full economic analyses the cost-
effectiveness of telehealth interventions in 
chronic heart failure remains unknown 
Jerant, A. F. 2005 Cost-effectiveness of heart failure 
disease management incorporating 
telehealth 
Cost-effectiveness of these programs is 
unproven 
Louis, A. A. 2003 Review of telemonitoring for the 
management of heart failure 
More study is needed before conclusions of 
cost-effectiveness can be determined 
Mistry, H. 2014 Critical appraisal of published 
systematic reviews assessing the cost-
effectiveness of telemedicine studies 
including COPD and CHF  
Conclusions cannot be drawn on the cost-
effectiveness of telemedicine applications 
based on the methodological flaws in the 
economic analysis of the studies included in 
the reviews 
                                                 
9 Network meta-analysis, in the context of a systematic review, is a meta-analysis in which multiple treatments (that 
is, three or more) are being compared using both direct comparisons of interventions within randomized controlled 
trials and indirect comparisons across trials based on a common comparator (Li et al., 2011). 
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Pandor, A. 2013 Systematic review and meta-analysis of 
telemonitoring after recent discharge in 
patients with heart failure 
Despite wide variation in usual care and 
remote monitoring strategies, cost-
effectiveness analyses suggest that 
telemonitoring during office hours was an 
optimal strategy 
Udsen, F. W. 2014 Systematic review of the cost and cost-
effectiveness of telehealth for patients 
suffering from chronic obstructive 
pulmonary disease 
Quality of the economic evidence was poor, 
no definite conclusions can be made 
 
V. Limitations and Strengths of the Literature 
 
The literature on cost-effectiveness of telehealth interventions has many limitations. First, there 
is a limited amount of research conducted on the topic for patients with chronic cardiovascular 
conditions and COPD. These included many studies with small sample sizes. Also, all the most 
recent research was done in Europe and Asia. It is difficult to draw conclusions from different 
countries because they have varying health systems. Many of the international studies were 
conducted in countries with universal healthcare  coverage. The most current American study was 
published in 2008. All three American studies were done in the Veterans Administration Health 
System, which is not reflective of the rest of the United States’ healthcare system where most 
people receive their care.  
The 9 literature reviews discussed conclude that studies with a stronger economic analysis 
component need to be conducted. These reviews looked at studies done in Australia, Europe, North 
America, and Taiwan. One reason for this limitation may be due to the United States’ government 
restriction on using the measure of “dollars per quality adjusted life year (QALY) as a threshold 
to establish what type of health care is cost effective or recommended” (The Patient Protection and 
Affordable Care Act, 2010) for the Medicare program. The Patient-Centered Outcomes Research 
Institute (PCORI) is therefore limited in the types of analyses it is able to support.  
Another limitation of the research is the variability in the cost-effectiveness of the same 
intervention depending on contextual factors such as study population demographics, local and 
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regional hospital environment, availability of social supports, and others. Providers need to be 
aware of the research to be sure it can be replicated in their setting.  
Another challenge to determining cost-effectiveness of telehealth programs is that many 
studies include multiple diseases and people with multiple co-morbidities. The likelihood of a 
person having co-morbidites increases with age, so it is difficult to determine the cost-effectiveness 
of a program for a singular chronic condition. Multiple studies reviewed included people with 
CHF, COPD, and/or diabetes to circumvent this issue. Also, these studies included multiple types 
of telehealth programs including telemonitoring and telecare. The technology costs for different 
types of telehealth vary wildly which makes it challenging to draw conclusions about the cost-
effectiveness of telehealth programs as a whole. Lastly, it is difficult to generalize cost-
effectiveness when countries have different thresholds for assessing cost-effectiveness.  
One of the strengths of this literature is the range of studies and study protocols that have been 
performed and that might serve as pilots for future studies. Also, the research included in this 
review studied different interventions in different countries. This too could be a basis for future 
research.   
IV. Discussion 
The current paucity of cost-effectiveness studies on telehealth, particularly in the United States, 
is an important barrier that may be slowing the implementation of these interventions and 
programs. As the population of the United States ages, the need for the improved management of 
chronic diseases such as COPD and CHF will continue to increase . Providing better care at lower 
costs is a critical goal moving forward. Many of the studies to-date looking at the cost-effectiveness 
of telehealth are limited by small sample sizes. There is a possibility that bringing telehealth 
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programs to scale can result in cost savings. In addition, the rapidly changing technology and costs 
of technology impact their cost-effectiveness and the generalizability of previous studies.  
If the United States’ Congress amends the restriction on funding research using QALYs, 
PCORI could broaden its support for cost-effectiveness studies, including those evaluating 
telehealth interventions. Cost is a major barrier to the adoption of telehealth services in the United 
States (Lin et al., 2018). If more studies  are able to demonstrate cost-effectiveness, this may lead 
to greater adoption of these interventions.  
Due to the limitations of the research, it is difficult to conclude if telehealth is a promising 
approach. Studies conducted on the cost-effectiveness of telehealth for patients with chronic 
cardiovascular diseases showed promising results, yet the studies conducted for patients with 
COPD did not conclusively show cost-effectiveness. Previous literature reviews also could not 
definitively conclude that telehealth was cost-effective. These reviews all call for further research 
before any conclusions can be made. 
VI. Conclusions 
In spite of the promise of telehealth interventions and programs to improve care and reduce 
costs for patients with chronic cardiovascular disease and COPD, based on currently available 
research,  it is difficult to conclude if  they are cost-effective. Due to the lack of U.S. studies, small 
sample sizes, and inconclusive results of previous studies, more research is needed.  Innovations 
in health information technology will continue to increase the opportunities for telehealth 
interventions as well as the cost-benefit tradeoffs. Thus, there is critical need for research that 
evaluates the cost-effectiveness of these new approaches. As the burden of chronic diseases 
continues to grow in an aging U.S. population, leveraging technology to improve access to care 
will remain a critical strategy, especially for disadvantaged and geographically isolated 
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populations. Ensuring that these new technologies are both effective and cost-effective is an 
important research priority. 
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